Unbiased AI-powered news
U.S. military officials detailed ongoing naval blockade operations targeting Iranian-linked vessels globally, emphasizing warship capabilities and allied partnerships. Statements highlighted the degraded state of Iranian command and control, with warnings against cease-fire violations. The assessment included updates on Iranian leadership and regional dynamics involving the Houthis and China.
The War ZoneU.S. is pursuing Iranian-linked ships worldwide as part of an ongoing blockade, according to the Chairman of the Joint Chiefs of Staff Dan Caine. This global effort aims to restrict support to Iran during a current cease-fire in the Middle East.
Officials described the challenges of enforcing the blockade in congested waters. Dan Caine compared operating the blockade to driving a sports car through a crowded supermarket parking lot on a busy weekend. U.S.
warships, including surface-to-air missiles, land attack cruise missiles, anti-ship missiles, anti-submarine rockets, torpedoes, and five-inch naval guns. These ships also feature electronic warfare systems and embarked helicopters.
Commander Brad Cooper stated that military partnerships in the region are stronger than ever.
He noted a defensive posture stretching from northern Iraq to the northern Arabian Gulf, involving countries such as Bahrain, UAE, Saudi Arabia, Qatar, Kuwait, and Jordan. Cooper highlighted the creation of a large air defense umbrella across the Middle East. U.S.
soldiers by name, according to Cooper. He described these nations as exceptional teammates committed to mutual defense. The assessment came during discussions of operations like Epic Fury.
These outlets didn't split into competing frames — coverage was uniform.
theepochtimes.comThe Food and Drug Administration approved enlicitide, sold as Lipfendra, on Thursday. The daily pill inhibits PCSK9 and carries a lower list price than existing injectable treatments.
news.ycombinator.comKalshi will allow bets on selected clinical trial results and full FDA decisions, starting with Phase 3 studies from established companies. The FDA separately approved Merck's Lipfendra cholesterol pill based on studies showing up to 60% LDL reduction.
The IndependentThe Joint Committee on Vaccination and Immunisation advised adding a teenage booster dose to the national schedule. The change follows an outbreak in Kent that killed two teenagers earlier in 2026.